Catalent Inc (CTLT) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CTLT - US1488061029 - Common Stock
63.48 USD
0 (0%)
63.5 USD
+0.02 (+0.03%)
Overall CTLT gets a fundamental rating of 3 out of 10. We evaluated CTLT against 191 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of CTLT have multiple concerns. CTLT has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year CTLT was profitable.
In the past year CTLT had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CTLT reported negative net income in multiple years.
Each year in the past 5 years CTLT had a positive operating cash flow.
1.2 Ratios
CTLT has a better Return On Assets (-4.25%) than 78.01% of its industry peers.
CTLT's Return On Equity of -11.66% is fine compared to the rest of the industry. CTLT outperforms 75.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.25% | ||
| ROE | -11.66% | ||
| ROIC | N/A |
ROA(3y)-2.82%
ROA(5y)-0.09%
ROE(3y)-8.14%
ROE(5y)-1.42%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 21.82%, CTLT is in line with its industry, outperforming 51.83% of the companies in the same industry.
In the last couple of years the Gross Margin of CTLT has declined.
CTLT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 21.82% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.68%
GM growth 5Y-7.41%
2. Health
2.1 Basic Checks
CTLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CTLT has been increased compared to 1 year ago.
The number of shares outstanding for CTLT has been increased compared to 5 years ago.
Compared to 1 year ago, CTLT has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.62, we must say that CTLT is in the distress zone and has some risk of bankruptcy.
CTLT has a Altman-Z score of 1.62. This is in the better half of the industry: CTLT outperforms 64.92% of its industry peers.
The Debt to FCF ratio of CTLT is 49.84, which is on the high side as it means it would take CTLT, 49.84 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 49.84, CTLT is doing good in the industry, outperforming 78.01% of the companies in the same industry.
CTLT has a Debt/Equity ratio of 1.38. This is a high value indicating a heavy dependency on external financing.
CTLT has a worse Debt to Equity ratio (1.38) than 74.87% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 49.84 | ||
| Altman-Z | 1.62 |
ROIC/WACCN/A
WACC9.31%
2.3 Liquidity
A Current Ratio of 2.51 indicates that CTLT has no problem at all paying its short term obligations.
CTLT has a Current ratio (2.51) which is in line with its industry peers.
CTLT has a Quick Ratio of 1.93. This is a normal value and indicates that CTLT is financially healthy and should not expect problems in meeting its short term obligations.
CTLT has a Quick ratio of 1.93. This is comparable to the rest of the industry: CTLT outperforms 44.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.51 | ||
| Quick Ratio | 1.93 |
3. Growth
3.1 Past
CTLT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -61.40%.
Measured over the past years, CTLT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -33.48% on average per year.
Looking at the last year, CTLT shows a small growth in Revenue. The Revenue has grown by 4.71% in the last year.
The Revenue has been growing by 11.71% on average over the past years. This is quite good.
EPS 1Y (TTM)-61.4%
EPS 3Y-56.51%
EPS 5Y-33.48%
EPS Q2Q%-30%
Revenue 1Y (TTM)4.71%
Revenue growth 3Y3.1%
Revenue growth 5Y11.71%
Sales Q2Q%4.18%
3.2 Future
The Earnings Per Share is expected to grow by 73.38% on average over the next years. This is a very strong growth
Based on estimates for the next years, CTLT will show a small growth in Revenue. The Revenue will grow by 7.44% on average per year.
EPS Next Y350.55%
EPS Next 2Y148.11%
EPS Next 3Y113.64%
EPS Next 5Y73.38%
Revenue Next Year8.33%
Revenue Next 2Y8.2%
Revenue Next 3Y8.33%
Revenue Next 5Y7.44%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 288.55, which means the current valuation is very expensive for CTLT.
Based on the Price/Earnings ratio, CTLT is valued a bit cheaper than 78.01% of the companies in the same industry.
CTLT is valuated expensively when we compare the Price/Earnings ratio to 26.22, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 41.25, the valuation of CTLT can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CTLT indicates a somewhat cheap valuation: CTLT is cheaper than 76.44% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CTLT to the average of the S&P500 Index (23.58), we can say CTLT is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 288.55 | ||
| Fwd PE | 41.25 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CTLT indicates a somewhat cheap valuation: CTLT is cheaper than 76.96% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CTLT is valued a bit cheaper than the industry average as 78.53% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 116.39 | ||
| EV/EBITDA | 36.47 |
4.3 Compensation for Growth
CTLT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CTLT's earnings are expected to grow with 113.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.82
PEG (5Y)N/A
EPS Next 2Y148.11%
EPS Next 3Y113.64%
5. Dividend
5.1 Amount
CTLT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
63.48
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners92.2%
Inst Owner Change-100%
Ins Owners0.48%
Ins Owner Change0%
Market Cap11.52B
Revenue(TTM)4.42B
Net Income(TTM)-413.00M
Analysts52.86
Price Target64.77 (2.03%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-149.78%
Min EPS beat(2)-336.02%
Max EPS beat(2)36.46%
EPS beat(4)1
Avg EPS beat(4)-365.14%
Min EPS beat(4)-1032.86%
Max EPS beat(4)36.46%
EPS beat(8)2
Avg EPS beat(8)-208.81%
EPS beat(12)5
Avg EPS beat(12)-141.22%
EPS beat(16)9
Avg EPS beat(16)-103.51%
Revenue beat(2)1
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-5.19%
Max Revenue beat(2)4.16%
Revenue beat(4)1
Avg Revenue beat(4)-1.79%
Min Revenue beat(4)-6.04%
Max Revenue beat(4)4.16%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)6
Avg Revenue beat(12)-0.33%
Revenue beat(16)8
Avg Revenue beat(16)-0.03%
PT rev (1m)0.11%
PT rev (3m)4.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-43.12%
EPS NY rev (1m)4.18%
EPS NY rev (3m)-6.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.9%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 288.55 | ||
| Fwd PE | 41.25 | ||
| P/S | 2.61 | ||
| P/FCF | 116.39 | ||
| P/OCF | 28.88 | ||
| P/B | 3.25 | ||
| P/tB | 31.57 | ||
| EV/EBITDA | 36.47 |
EPS(TTM)0.22
EY0.35%
EPS(NY)1.54
Fwd EY2.42%
FCF(TTM)0.55
FCFY0.86%
OCF(TTM)2.2
OCFY3.46%
SpS24.36
BVpS19.51
TBVpS2.01
PEG (NY)0.82
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.25% | ||
| ROE | -11.66% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 21.82% | ||
| FCFM | 2.24% |
ROA(3y)-2.82%
ROA(5y)-0.09%
ROE(3y)-8.14%
ROE(5y)-1.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.68%
GM growth 5Y-7.41%
F-Score5
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 49.84 | ||
| Debt/EBITDA | 11.05 | ||
| Cap/Depr | 61.22% | ||
| Cap/Sales | 6.78% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 90.27% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.51 | ||
| Quick Ratio | 1.93 | ||
| Altman-Z | 1.62 |
F-Score5
WACC9.31%
ROIC/WACCN/A
Cap/Depr(3y)125.99%
Cap/Depr(5y)159.79%
Cap/Sales(3y)11.57%
Cap/Sales(5y)13.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-61.4%
EPS 3Y-56.51%
EPS 5Y-33.48%
EPS Q2Q%-30%
EPS Next Y350.55%
EPS Next 2Y148.11%
EPS Next 3Y113.64%
EPS Next 5Y73.38%
Revenue 1Y (TTM)4.71%
Revenue growth 3Y3.1%
Revenue growth 5Y11.71%
Sales Q2Q%4.18%
Revenue Next Year8.33%
Revenue Next 2Y8.2%
Revenue Next 3Y8.33%
Revenue Next 5Y7.44%
EBIT growth 1Y-166.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year196.68%
EBIT Next 3Y58.17%
EBIT Next 5Y41.23%
FCF growth 1Y121.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y116.85%
OCF growth 3Y-14.78%
OCF growth 5Y1.59%
Catalent Inc / CTLT FAQ
What is the ChartMill fundamental rating of Catalent Inc (CTLT) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CTLT.
What is the valuation status for CTLT stock?
ChartMill assigns a valuation rating of 4 / 10 to Catalent Inc (CTLT). This can be considered as Fairly Valued.
What is the profitability of CTLT stock?
Catalent Inc (CTLT) has a profitability rating of 3 / 10.
What are the PE and PB ratios of Catalent Inc (CTLT) stock?
The Price/Earnings (PE) ratio for Catalent Inc (CTLT) is 288.55 and the Price/Book (PB) ratio is 3.25.
What is the earnings growth outlook for Catalent Inc?
The Earnings per Share (EPS) of Catalent Inc (CTLT) is expected to grow by 350.55% in the next year.